Division of Bacterial Respiratory Infections, Center for Infectious Diseases, National Institute of Health, Korea Centers for Disease Control and Prevention, Chungcheongbuk-do, Korea.
NeoDin Medical Institute, Seoul, Korea.
Epidemiol Infect. 2013 Mar;141(3):481-9. doi: 10.1017/S0950268812001082. Epub 2012 May 30.
This study investigated the carriage of antimicrobial resistant Haemophilus influenzae in 582 healthy children attending kindergarten or elementary school at four intervals over a 9-month period in Seoul, Korea. Diverse colonization patterns and a lower level of long-term persistent carriage by H. influenzae status were evident in this study. Colonizing H. influenzae isolates showed a high rate of resistance to β-lactams including ampicillin (51·9%), cefaclor (52·1%), and amoxicillin/clavulanate (16·3%). Based on the ampicillin resistance mechanism, H. influenzae isolates were categorized as β-lactamase-negative, ampicillin-susceptible (BLNAS) (48·1%), β-lactamase-positive, ampicillin-resistant (BLPAR) (22·6%), β-lactamase-negative, ampicillin-resistant (BLNAR) (22·8%), and β-lactamase-positive, amoxicillin/clavulanate-resistant (BLPACR) strains (6·5%). This study provides the first evidence of a high prevalence (22·8%) of BLNAR strains of H. influenzae nasal carriage in healthy children attending kindergarten or the first 2 years of elementary school in Korea. The high carriage of these resistant strains in overcrowded urban settings may create reservoirs for development of H. influenzae-resistant strains.
本研究调查了 582 名在韩国首尔的幼儿园或小学就读的健康儿童在 9 个月的 4 个时间间隔内携带耐抗菌药物的流感嗜血杆菌的情况。本研究表明,存在不同的定植模式和较低水平的流感嗜血杆菌长期持续定植状态。定植的流感嗜血杆菌分离株对包括氨苄西林(51.9%)、头孢克洛(52.1%)和阿莫西林/克拉维酸(16.3%)在内的β-内酰胺类药物具有较高的耐药率。根据氨苄西林耐药机制,流感嗜血杆菌分离株可分为β-内酰胺酶阴性、氨苄西林敏感(BLNAS)(48.1%)、β-内酰胺酶阳性、氨苄西林耐药(BLPAR)(22.6%)、β-内酰胺酶阴性、氨苄西林耐药(BLNAR)(22.8%)和β-内酰胺酶阳性、阿莫西林/克拉维酸耐药(BLPACR)菌株(6.5%)。本研究首次提供了在韩国上幼儿园或小学前 2 年的健康儿童中,鼻腔携带流感嗜血杆菌 BLNAR 株的高流行率(22.8%)的证据。在人口密集的城市环境中,这些耐药株的高携带率可能会为流感嗜血杆菌耐药株的产生创造储库。